Copyright
©The Author(s) 2019.
World J Gastrointest Oncol. Jul 15, 2019; 11(7): 527-537
Published online Jul 15, 2019. doi: 10.4251/wjgo.v11.i7.527
Published online Jul 15, 2019. doi: 10.4251/wjgo.v11.i7.527
Table 1 Diagnostic criteria for sarcopenia by various working groups
Criteria | Remarks | |
European Working Group on Sarcopenia in Older People, 2010[16] | 1 Low muscle strength | Probable sarcopenia is identified by Criterion 1 |
2 Low muscle quantity or quality | Diagnosis is confirmed by additional documentation of Criterion 2 | |
3 Low physical performance | Sarcopenia is considered severe if all 3 criteria are met | |
ESPEN Special Interest Group, 2010[18] | 1 Low muscle mass | Cut-off point should be more than 2 standard deviations below mean value of reference population using young adults of the same sex and ethnic background |
2 Walking speed < 0.8 m/s in the 4-min test or reduced performance in functional test | Functional test can be any test used for comprehensive geriatric assessment Both criteria should be present | |
International Working Group on Sarcopenia, 2011[17] | 1 Gait speed < 1 m/s 2 Lean mass less than the 20th percentile of values for healthy young adults | Both criteria should be present |
European Working Group on Sarcopenia in Older People, 2018 [2] | 1 Low muscle mass | Cut-off point should be more than 2 standard deviations below mean value of reference population using healthy young adults of the same ethnic background |
2 Low muscle strengt | Diagnosis is based on documentation of Criterion 1 plus Criterion 2 or Criterion 3 | |
3 Low physical performance | ||
Society of Sarcopenia, Cachexia and Wasting Disorders, 2011[19] | 1 Walking speed ≤ 1 m/s or < 400 m during 6-min walk | Both criteria should be present |
2 Lean appendicular mass corrected for height squared of more than 2 standard deviations below healthy adults of 20–30 years old of the same ethnic group |
- Citation: Chan MY, Chok KSH. Sarcopenia in pancreatic cancer – effects on surgical outcomes and chemotherapy. World J Gastrointest Oncol 2019; 11(7): 527-537
- URL: https://www.wjgnet.com/1948-5204/full/v11/i7/527.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v11.i7.527